FdaApplication

NDA 011284

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMEDPOINTE PHARMACEUTICALS MEDPOINTE HEALTHCARE INC
application_typeNDA

Products (2)

ProductActive ingredientStrengthDosage form
MEPROSPANMEPROBAMATE400MGCAPSULE, EXTENDED RELEASE;ORAL
MEPROSPANMEPROBAMATE200MGCAPSULE, EXTENDED RELEASE;ORAL

2 products